Fibrinogen and Hemostasis: A Primary Hemostatic Target for the Management of Acquired Bleeding

The prospective study of fibrinogen supplementation in acquired bleeding is needed to accurately assess the range of clinical settings in which this management strategy is appropriate, the most effective method of supplementation and a comprehensive safety profile of fibinogen concentrate used for such an approach.